BACKGROUND: Tobacco smoking is common in human immunodeficiency virus (HIV) infected patients from industrialised countries. In West Africa, few data concerning tobacco consumption exist. METHODS: A cross-sectional survey of the International Epidemiological Database to Evaluate AIDS (IeDEA) network in West Africa was conducted. Health workers administered a questionnaire assessing tobacco and cannabis consumption among patients receiving antiretroviral treatment. Regular smokers were defined as current smokers who smoked >1 cigarette per day for >or=1 year. RESULTS: Overall, 2920 patients were enrolled in three countries. The prevalence of ever smokers and regular smokers were respectively 46.2% (95%CI 42.8-49.5) and 15.6% (95%CI 13.2-18.0) in men and 3.7% (95%CI 2.9-4.5) and 0.6% (95%CI 0.3-0.9) in women. Regular smoking was associated with being from Côte d'Ivoire or Mali compared to Benin (OR 4.6, 95%CI 2.9-7.3 and 7.7, 95%CI 4.4-13.6), severely impaired immunological status at highly active antiretroviral treatment initiation (OR 1.5, 95%CI 1.1-2.2) and history of tuberculosis (TB; OR 1.8, 95%CI 1.1-3.0). CONCLUSION: There are marked differences in smoking prevalence among these West African countries. This survey approach also provides proof of the association between cigarette smoking and TB in HIV-infected patients, a major public health issue in this part of the world.
BACKGROUND:Tobacco smoking is common in human immunodeficiency virus (HIV) infectedpatients from industrialised countries. In West Africa, few data concerning tobacco consumption exist. METHODS: A cross-sectional survey of the International Epidemiological Database to Evaluate AIDS (IeDEA) network in West Africa was conducted. Health workers administered a questionnaire assessing tobacco and cannabis consumption among patients receiving antiretroviral treatment. Regular smokers were defined as current smokers who smoked >1 cigarette per day for >or=1 year. RESULTS: Overall, 2920 patients were enrolled in three countries. The prevalence of ever smokers and regular smokers were respectively 46.2% (95%CI 42.8-49.5) and 15.6% (95%CI 13.2-18.0) in men and 3.7% (95%CI 2.9-4.5) and 0.6% (95%CI 0.3-0.9) in women. Regular smoking was associated with being from Côte d'Ivoire or Mali compared to Benin (OR 4.6, 95%CI 2.9-7.3 and 7.7, 95%CI 4.4-13.6), severely impaired immunological status at highly active antiretroviral treatment initiation (OR 1.5, 95%CI 1.1-2.2) and history of tuberculosis (TB; OR 1.8, 95%CI 1.1-3.0). CONCLUSION: There are marked differences in smoking prevalence among these West African countries. This survey approach also provides proof of the association between cigarette smoking and TB in HIV-infectedpatients, a major public health issue in this part of the world.
Authors: Aline Simen-Kapeu; Guy La Ruche; Vesa Kataja; Merja Yliskoski; Christine Bergeron; Apollinaire Horo; Kari Syrjänen; Seppo Saarikoski; Matti Lehtinen; François Dabis; Annie J Sasco Journal: Cancer Causes Control Date: 2008-09-24 Impact factor: 2.506
Authors: Fred M Gordin; Mollie P Roediger; Pierre-Marie Girard; Jens D Lundgren; Jose M Miro; Adrian Palfreeman; Maria C Rodriguez-Barradas; Marcelo J Wolff; Philippa J Easterbrook; Kate Clezy; Leonard N Slater Journal: Am J Respir Crit Care Med Date: 2008-07-10 Impact factor: 21.405
Authors: Nina Friis-Møller; Rainer Weber; Peter Reiss; Rodolphe Thiébaut; Ole Kirk; Antonella d'Arminio Monforte; Christian Pradier; Linda Morfeldt; Silvia Mateu; Matthew Law; Wafaa El-Sadr; Stephan De Wit; Caroline A Sabin; Andrew N Phillips; Jens D Lundgren Journal: AIDS Date: 2003-05-23 Impact factor: 4.177
Authors: G La Ruche; R Ramon; I Mensah-Ado; C Bergeron; M Diomandé; F Sylla-Koko; A Ehouman; K Touré-Coulibaly; C Welffens-Ekra; F Dabis Journal: Cancer Date: 1998-06-15 Impact factor: 6.860
Authors: Andrea H Weinberger; Philip H Smith; Allison P Funk; Shayna Rabin; Jonathan Shuter Journal: J Acquir Immune Defic Syndr Date: 2017-04-01 Impact factor: 3.731
Authors: Jessica L Elf; Ebrahim Variava; Sandy Chon; Limakatso Lebina; Katlego Motlhaoleng; Nikhil Gupte; Raymond Niaura; David Abrams; Jonathan E Golub; Neil Martinson Journal: Nicotine Tob Res Date: 2018-08-14 Impact factor: 4.244
Authors: Rachel M Amiya; Krishna C Poudel; Kalpana Poudel-Tandukar; Jun Kobayashi; Basu D Pandey; Masamine Jimba Journal: BMC Public Health Date: 2011-08-31 Impact factor: 3.295
Authors: Jialun Zhou; Antoine Jaquet; Emmanuel Bissagnene; Beverly Musick; Kara Wools-Kaloustian; Nicola Maxwell; Andrew Boulle; Firas Wehbe; Daniel Masys; Jeniffer Iriondo-Perez; Jay Hemingway-Foday; Matthew Law Journal: J Int AIDS Soc Date: 2012-01-30 Impact factor: 5.396
Authors: Nhung Phuong Thi Nguyen; Bach Xuan Tran; Lu Y Hwang; Christine M Markham; Michael D Swartz; Huong Thu Thi Phan; Vuong Minh Nong; Cuong Tat Nguyen; Anh Hue Nguyen; Carl A Latkin; Damon J Vidrine Journal: PLoS One Date: 2015-02-27 Impact factor: 3.240
Authors: Thiago S Torres; Paula M Luz; Monica Derrico; Luciane Velasque; Eduarda Grinsztejn; Valdiléa G Veloso; Sandra W Cardoso; Marília Santini-Oliveira; Beatriz Grinsztejn; Raquel Brandini De Boni Journal: PLoS One Date: 2014-12-23 Impact factor: 3.240
Authors: Marcellin N Nouaman; David G Meless; Patrick A Coffie; Elise Arrivé; Boris K Tchounga; Didier K Ekouévi; Camille Anoma; Serge P Eholié; François Dabis; Antoine Jaquet Journal: BMC Oral Health Date: 2015-12-02 Impact factor: 2.757
Authors: Antoine Jaquet; Franck Garanet; Eric Balestre; Didier K Ekouevi; Jean Claude Azani; René Bognounou; Elias Dah; Jean Charlemagne Kondombo; François Dabis; Joseph Drabo Journal: J Int AIDS Soc Date: 2013-12-18 Impact factor: 5.396